"Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes" by Alena Gros

Article

Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes

Journal for ImmunoTherapy of Cancer (2015)

Alena Gros, National Institutes of Health
Eric Tran, National Institutes of Health
Maria R Parkhurst, National Institutes of Health
Pasetto Anna, National Institutes of Health
Sadia Ilyas, National Institutes of Health
Todd D Prickett, National Institutes of Health
Jared J Gartner, National Institutes of Health
Paul F Robbins, National Institutes of Health
Jessica S Crystal, National Institutes of Health
Kasia Trebska-Mcgowan, National Institutes of Health
John R Wudnerlich, National Institutes of Health
James C Yang, National Institutes of Health
Steven A Rosenberg, National Institutes of Health

Link

Disciplines

Publication Date

January 1, 2015

DOI

10.1186/2051-1426-3-S2-O2

Citation Information

Alena Gros, Eric Tran, Maria R Parkhurst, Pasetto Anna, et al.. "Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes" Journal for ImmunoTherapy of Cancer Vol. 3 Iss. 2 (2015)
Available at: http://works.bepress.com/eric-tran/14/